Viewing Study NCT06920251


Ignite Creation Date: 2025-12-24 @ 11:48 PM
Ignite Modification Date: 2025-12-30 @ 1:19 PM
Study NCT ID: NCT06920251
Status: RECRUITING
Last Update Posted: 2025-12-03
First Post: 2025-03-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase II Trials of Letermovir Prophylaxis in Patients With RRMM Undergoing Elranatamab Therapy
Sponsor: Seoul National University Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module